发明名称 ANTITUMOR EFFECT POTENTIATOR COMPOSED OF IMIDAZOOXAZINE COMPOUND
摘要 An antitumor effect potentiator for potentiating one or more other antitumor agents, comprising, as an active ingredient, an imidazooxazine compound represented by Formula (I), or a pharmaceutically acceptable salt thereof, wherein A, B, C, and D represent C-R 1a , C-R 1b , C-R 1c , and C-R 1d , respectively, or one or two of A, B, C, and D represent an N atom; at least two of R 1a , R 1b , R 1c , and R 1d represent hydrogen, and the other(s) represent(s) halogen; cyano; C 1-6 alkyl that may have hydroxyl group(s) as substituent(s); C 1-6 alkoxy; carbonyl having, as a substituent, hydroxyl, amino, optionally substituted mono- or di-(C 1-6 alkyl)amino, or mono- or di-(C 1-6 alkoxy)amino; or an unsaturated heterocyclic group; R 2 represents phenyl, pyridyl, or thienyl; R 3 represents hydrogen, methyl, ethyl, or cyclopropyl; and R 4 represents hydrogen or hydroxy.
申请公布号 EP2868660(A1) 申请公布日期 2015.05.06
申请号 EP20130813275 申请日期 2013.07.01
申请人 TAIHO PHARMACEUTICAL CO., LTD. 发明人 ICHIKAWA, KOJI;OKADA, MEGUMU
分类号 A61K31/337;A61K31/155;A61K31/436;A61K31/4412;A61K31/4745;A61K31/513;A61K31/517;A61K31/53;A61K31/5365;A61K31/5383;A61K31/555;A61K31/69;A61K31/704;A61K45/06;A61P35/00;A61P43/00;C07D498/04;C07D498/14 主分类号 A61K31/337
代理机构 代理人
主权项
地址